Results

Total Results: 1,210 records

Showing results for "death".

  1. S143 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - Subjects were censored on the occurrence of death, disenroll- ment, discontinuity of enrollment, or July … Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
    March 10, 2010 - We felt that cardiovascular mortality (which included death from vascular causes such as stroke) was … an inherently different endpoint than cardiac death which justified them being assessed separately.
  3. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
    December 01, 2011 - ventricular systolic dysfunction, and an increased risk of a major adverse cardiovascular event (MACE) or death … found that use of catheter aspiration, age, and symptom to balloon time were significant predictors of cardiacdeath (no deaths were of noncardiac cause) at 2 years. … Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention … death.
  4. effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
    July 18, 2017 - Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Clinician Summary Archived July 18, 2017 Download Main Document PDF 897.3 KB Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current. …
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
    July 01, 2017 - Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence Focus of This Summary This is a summary of a systematic review that evaluated the recent evidence regarding the benefits and adve…
  6. effectivehealthcare.ahrq.gov/products/substance-use-disorders-adolescents/protocol
    October 29, 2018 - and physical health problems. 7 Adolescent substance use is associated with the leading causes of death … opiates (e.g., heroin), have brought heightened attention to the significant risk of drug overdose death
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hnhc-disposition-comments.pdf
    October 29, 2021 - interpretation of LCA and k-means outputs, and demonstrates significant differences in 1-year outcomes (death
  8. effectivehealthcare.ahrq.gov/sites/default/files/malnutrition-hospitalized-adults-draft-appendixes.pdf
    April 08, 2021 - Events Bonilla- Palomas et al. 201645 1-month mortality, %: Tx: 0.07; CG: 0.11, p=NR 3-month death … from any cause, %: Tx: 0.14; CG: 0.26, p=NR 6-month death from any cause, %: Tx: 0.15; CG: … 0.36, p=NR 12-month death from any cause, %: Tx: 0.203; CG: 0.475, p=0.003 NR 1-month readmission … CG: 8.7%, p=0.020 90-day mortality, %: ONS: 4.8%; CG: 9.7%, p=0.018 The NNT to prevent 1 death
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading cause of cancer death
  10. effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading cause of cancer death
  11. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
    December 01, 2009 - Layout 1 Background Breast cancer is the second most common malignancy of women, with over 180,000 new cases diagnosed each year in the United States. Survival rates depend on the stage of disease at diagnosis. Women diagnosed with early stages of breast cancer have a 5-year survival rate near 100 percent. However, …
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
    November 01, 2014 - lengths of stay and costs of care; in one report from Asian countries, they were associated with death … ventilation 1 prospective cohort (n=638) High NA Direct Imprecise Insufficient Mortality (composite of death … response or days on a ventilator—or preferably, patient-centered health outcomes, especially disease or death
  13. effectivehealthcare.ahrq.gov/products/alcohol-misuse/research-protocol
    July 22, 2011 - Actual causes of death in the United States, 2000. JAMA 2004 Mar 10;291(10):1238-45.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
    November 20, 2013 - This SHFM predicts mode of death given clinical, diagnostic and laboratory data for ambulatory patients … protein, N- terminal proBNP, and cardiac troponin T and I in end stage renal disease for subsequent death … The Protect study was not included as it was unclear whether the reported of death as cardiovascular … death included all deaths.
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
    September 01, 2014 - therapy had greater increases in their HDL-c, there were no benefits on incidence of cardiovascular death … IMPROVE-IT trial will compare ezetimibe added to simvastatin to simvastatin monotherapy on cardiovascular death … superior lipid outcomes, but fails to reduce atherosclerosis or lead to decreased rates of cardiovascular death … lipid outcomes, but fails to reduce atherosclerosis or lead to decreased rates of cardiovascular death … therapy can lead to superior lipid outcomes, but fail to reduce clinical outcomes such as cardiovascular death
  16. effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
    April 01, 2020 - Pregabalin and the risk for opioid-related death: a nested case-control study. … Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study
  17. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/genitourinary-syndrome-key-questions.pdf
    January 01, 2021 - Systemic adverse events: chronic pain, CVA (stroke); VTE (DVT); death; hot flashes; headache; breast
  18. effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
    March 01, 2011 - CAD causes one in six deaths in the United States and is the leading cause of death globally.1 … life • Revascularization • Change in angina • Myocardial infarction • Heart failure • Stroke • Death … For studies of predictive accuracy, only hard clinical outcomes (i.e., MI, death, composite cardiac … No major complications were attributed to the imaging procedure; 30-day death, MI, and stroke were … echocardiography with exercise ECG; this trial reported similar frequency of a composite outcome that included cardiac
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
    February 01, 2006 - Layout 1 Background Breast cancer is the second most common malignancy in women. The American Cancer Society estimated that in the United States in 2005, 212,930 women would be newly diagnosed as having breast cancer and there would be 40,870 deaths due to this disease. Because early breast cancer is asymptomatic, th…
  20. effectivehealthcare.ahrq.gov/sites/default/files/cer-221-copd-evidence-summary.pdf
    October 01, 2019 - diseases, of which COPD is the largest contributing condition, are the fourth leading cause of death … Patients hospitalized with COPD exacerbations are at high risk for hospital readmissions and death

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: